Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuewen Pan

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Cell Reports|February 19, 2013
A functional variomics tool for discovering drug-resistance genes and drug targetsZhiwei Huang, Kaifu Chen, Jianhuai Zhang, et al.
Molecular Cell|July 11, 2008
Acetylation of Smc3 by Eco1 is required for S phase sister chromatid cohesion in both human and yeastJinglan Zhang, Xiaomin Shi, Yehua Li, et al.
Msphere|January 10, 2020
Puupehenone, a Marine-Sponge-Derived Sesquiterpene Quinone, Potentiates the Antifungal Drug Caspofungin by Disrupting Hsp90 Activity and the Cell Wall Integrity PathwaySiddharth K Tripathi, Qin Feng, Li Liu, et al.
ACS Chemical Biology|November 22, 2018
Previously Uncharacterized Vacuolar-type ATPase Binding Site Discovered from Structurally Similar Compounds with Distinct Mechanisms of ActionAndrew C Wang, Helen T Pham, Jennifer M Lipps, et al.
The Journal of Biological Chemistry|August 20, 2017
Two plant-derived aporphinoid alkaloids exert their antifungal activity by disrupting mitochondrial iron-sulfur cluster biosynthesisSiddharth K Tripathi, Tao Xu, Qin Feng, et al.
Nature Biotechnology|July 15, 2020
Optimization of AsCas12a for combinatorial genetic screens in human cellsPeter C DeWeirdt, Kendall R Sanson, Annabel K Sangree, et al.
Angewandte Chemie (International Ed. in English)|July 17, 2015
Nannocystin A: an Elongation Factor 1 Inhibitor from Myxobacteria with Differential Anti-Cancer PropertiesPhilipp Krastel, Silvio Roggo, Markus Schirle, et al.
Molecular Cancer Therapeutics|May 6, 2025
CRISPR screens identify POLB as a synthetic lethal enhancer of PARP inhibition exclusively in BRCA-mutated tumorsKatherine Lazarides, Justin L Engel, Michele Meseonznik, et al.
Cell Reports Methods|June 1, 2026
Temporal control of sgRNA library activation unlocks large-scale in vivo CRISPR screensSilvia Fenoglio, Yi Yu, James Tepper, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|October 16, 2025
Tumor suppressor collateral damage screens reveal mRNA homeostasis protein HBS1L as a novel vulnerability in ch9p21 driven FOCAD deleted cancerHongxiang Zhang, Matthew R Tonini, Lauren Catherine M Martires, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Cell Reports|February 19, 2013
A functional variomics tool for discovering drug-resistance genes and drug targetsZhiwei Huang, Kaifu Chen, Jianhuai Zhang, et al.
Molecular Cell|July 11, 2008
Acetylation of Smc3 by Eco1 is required for S phase sister chromatid cohesion in both human and yeastJinglan Zhang, Xiaomin Shi, Yehua Li, et al.
Msphere|January 10, 2020
Puupehenone, a Marine-Sponge-Derived Sesquiterpene Quinone, Potentiates the Antifungal Drug Caspofungin by Disrupting Hsp90 Activity and the Cell Wall Integrity PathwaySiddharth K Tripathi, Qin Feng, Li Liu, et al.
ACS Chemical Biology|November 22, 2018
Previously Uncharacterized Vacuolar-type ATPase Binding Site Discovered from Structurally Similar Compounds with Distinct Mechanisms of ActionAndrew C Wang, Helen T Pham, Jennifer M Lipps, et al.
The Journal of Biological Chemistry|August 20, 2017
Two plant-derived aporphinoid alkaloids exert their antifungal activity by disrupting mitochondrial iron-sulfur cluster biosynthesisSiddharth K Tripathi, Tao Xu, Qin Feng, et al.
Nature Biotechnology|July 15, 2020
Optimization of AsCas12a for combinatorial genetic screens in human cellsPeter C DeWeirdt, Kendall R Sanson, Annabel K Sangree, et al.
Angewandte Chemie (International Ed. in English)|July 17, 2015
Nannocystin A: an Elongation Factor 1 Inhibitor from Myxobacteria with Differential Anti-Cancer PropertiesPhilipp Krastel, Silvio Roggo, Markus Schirle, et al.
Molecular Cancer Therapeutics|May 6, 2025
CRISPR screens identify POLB as a synthetic lethal enhancer of PARP inhibition exclusively in BRCA-mutated tumorsKatherine Lazarides, Justin L Engel, Michele Meseonznik, et al.
Cell Reports Methods|June 1, 2026
Temporal control of sgRNA library activation unlocks large-scale in vivo CRISPR screensSilvia Fenoglio, Yi Yu, James Tepper, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|October 16, 2025
Tumor suppressor collateral damage screens reveal mRNA homeostasis protein HBS1L as a novel vulnerability in ch9p21 driven FOCAD deleted cancerHongxiang Zhang, Matthew R Tonini, Lauren Catherine M Martires, et al.
Pageof 5